Systemic Therapy of Primary Cutaneous B-cell Lymphoma, Marginal Zone Type, with Rituximab, a Chimeric Anti-CD20 Monoclonal Antibody
R. Soda, A. Costanzo, M. Cantonetti, A. Orlandi, L. Bianchi, S. Chimenti
DOI: 10.1080/000155501750376339
Abstract
This article does not have an abstract.
Significance
Supplementary content
Comments
